Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice

FEMS Immunology and Medical Microbiology

Volumn 26, Issue 3-4, 1999, Pages 299-307

  Kullberg, Bart Jan ^a   Netea, Mihai G ^a   Vonk, Alieke G ^a   Van Der Meer, Jos W M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Candida albicans; Fluconazole; Granulocyte colony stimulating factor; Neutrophil; Tumor necrosis factor

Indexed keywords

FLUCONAZOLE; INTERLEUKIN 6; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CANDIDA ALBICANS; CANDIDIASIS; CELL FUNCTION; CONTROLLED STUDY; DRUG POTENTIATION; HOST RESISTANCE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; MICE; NEUTROPHILS;

EID: 0033485687     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00150-9     Document Type: Article

References (39)

1. Pfaller, M.A., Jones, R.N., Messer, S.A., Edmond, M.B. and Wenzel, R.P. (1998) National surveillance of nosocomial blood stream infection due to species of Camlitlu other than Candida albicam: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 30, 121-129.
2. Uzun, O. and Anaissie, E.J. (1996) Problems and controversies in the management of hematogenous candidiasis. Clin. Infect. Dis. 22 (2), S73-S88.
3. Rex, J.H., Bennett, J.E., Sugar, A.M., Pappas, P.C., Van der Horst, C.M., Edwards, J.E., Washburn, R.G., Scheid, W.M., Karchmer, A.W., Dine, A.P., Levenstein, M.J. and Webb, C.D. (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331, 1325-1330.
4. Anaissie, E.J., Abi-Said, D., Uzun, O., Mera, J., Gentry, L.O., Williams, T., Kontoyiannis, D.P., Karl, C.L. and Bodey, O.P. (1996) Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin. Infect. Dis. 23, 972-974.
5. Bodey, G.P. (1984) Candidiasis in cancer patients. Am. J. Med. 77 (4D), 13-19.
6. Van 't Wout, J.W., Linde, L, Leijh, P.C.J. and Van Furth, R. (1988) Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida alhicans infections. Eur. J. Clin. Microbiol. Infect. Dis. 7, 736-741.
7. Kullberg, B.J., Vandewoude, K., Herbrecht, R., Jacobs, F., Aoun, M., Kujath, P. (1998) A double-blind, randomized, placebo-controlled Phase II study of filgrastim (recombinant granulocyte colony-stimulating factor) in combination with fluconazole for treatment of invasive candidiasis and candidemia in nonneutropenic patients, Abstr. J100, p. 479. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA.
8. Marodi, L., Schreiber, S., Anderson, D.C., MacDermott, R.P., Korchak, U.M. and Johnston Jr., R.B. (1993) Enhancement of macrophage candidacidal activity by interferon-y. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannosc receptors. J. Clin. Invest. 91, 2596-2601.
9. Yamamoto, Y., Klein, T.W., Friedman, H., Kimura, S. and Yamaguchi, H. (1993) Granulocyte colony-stimulating factor potentiates a.n\\-Cand"ula alhicans growth inhibitory activity of polymorphonuclear cells. FEMS Immunol. Med. Microbiol. 7, 15-22.
10. Djeu, J.Y., Blanchard, O.K.., Halkias, D. and Friedman, H. (1986) Growth inhibition of Candida albiams by human polymorphonuclear neutrophils: activation by interferon-y and tumor necrosis factor. J. Immunol. 137, 2980-2984.
11. Diamond, R.D., Lyman, CA. and Wysong, D.R. (1991) Disparate effects of interferon-y and tumor necrosis factor-a on early neutrophil respiratory burst and fungicidal responses to Candida albiams hyphae in vitro. J. Clin. Invest. 87, 711-720.
12. Levitz, S.M. (1992) Overview of host defenses in fungal infections. Clin. Infect. Dis. 14, 37-42.
13. Dalrymple, S.A., Lucian, L.A., Slattery, R., McNeil, T., Aud. D.M., Fuchino, S., Lee, F. and Murray, R. (1995) Interleukin6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63, 2262-2268.
14. Yamamoto, Y., Klein, T.W. and Friedman, H. (1997) Involvement of mannosc receptor in cytokine interleukin-lbeta (IL-lbeta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein Ibeta (MIP-Ibeta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect. Immun. 65, 1077-10S2.
15. Steinshamn, S. and Waage, A. (1992) Tumor necrosis factor and interIeukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun. 60, 4003-4008.
16. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C, Puccetti, P., Bistoni, F. and Poli, V. (1996) Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183, 1345-1355.
17. Van Enckcvort, F., Netea, M.G., Hermus, A.R.M.M., Sweep, C.G.J., Meis, J.F.G.M., Van der Meer, J.W.M. and Kullberg, B.J. (1999) Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med. Mycol. (in press).
18. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Puccetti, P. and Bistoni, F. (1993) CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150, 925-931.
19. Romani, L., Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Tonnetti, L., Grohmann, U. and Bistoni, F. (1994) Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152, 3514-3521.
20. Tonnetti, L., Spaccapelo, R., Cenci, E.. Mencacci, A., Puccetti, P., CofTman, R.L., Bistoni, F. and Romani, L. (1995) Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 25, 1559-1565.
21. Romani, L., Mencacci, A., Tonnetti, L., Spaccapelo, R., Cenci, E., Puccetti, P., Wolf, S.F. and Bistoni, F. (1994) IL-I2 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153, 51675175.
22. Louie, A., Baltch, A.L., Smith, R.P., Franke, M.A., Ritz, W.J., Singh, J.K. and Gordon, M.A. (1994) Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect. Immun. 62, 2761-2772.
23. Netea, M.G., Blok, W.L., Kullberg, B.J., Bemelmans, M., Vogels, M.T.E., Buurman, W.A. and Van der Meer, J.W.M. (1995) Pharmacological inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J. Infect. Dis. 171, 393-399.
24. Marino, M.W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wida, H., Moore, M., Williamson, B., Basu, S. and Old, L.J. (1997) Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sei. USA 94, 8093-8098.
25. Netea, M.G., Van Tits, L.H.J., Curfs, J.A.H.J., Amiot, F., Meis, J.F.G.M., Van der Meer, J.W.M. and Kullberg, B.J. (1999) Increased susceptibility of TNFaLTct double knockout mice to systemic candidiasis through defective recruitment of neutrophils and phagocytosis of Candida albicans. J. Immunol. 163, 1498-1505.
26. Sata, M. and Walsh, K. (1998) TNFct regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat. Med. 4, 415-420.
27. Netea, M.G., Van der Meer, J.W.M., Meis, J.F.G.M. and Kullberg, B.J. (1999) Fas-FasL interactions modulate host defense against systemic Candida albicans infection. J. Infect. Dis. (in press).
28. Mclntyre, K.W., Stepan, G.J., Kolinsky, K.D., Benjamin, W.R., Plocinski, J.M., Kaffka, K.L., Campen, C.A., Chizzonite, R.A. and Kilian, P.L. (1991) Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL- 1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J. Exp. Med. 173, 931-939.
29. Kullberg. B.J., Van 't Wout, J.W. and Van Furth, R. (1991) No effect of recombinant human interleukin-I on the numbers of peripheral blood and peritoneal leukocytes during an acute inflammation. Inflammation 15, 457-470.
30. Lieschke, G.J. and Burgess, A.W. (1992) Drug therapy: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts). N. Engl. J. Med. 327, 28-35.
31. Weite, K., Gabrilove, J.L., Bronchud, M.H., Platze, r.E. and Morstyn, G. (1996) Filgrastim (r-metHuG-CSF): The First 10 Years. Blood 88, 1907-1929.
32. Matsumoto, M., Matsubara, S., Matsuno, T., Ono, M. and Yokota, T. (1990) Protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) against various microbial infections in neutropenic mice. Microbiol. Immunol. 34, 765-773.
33. Polak-Wyss, A. (1991) Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Candida infections in normal and immunosupprcsscd mice. Mycoses 34, 109-118.
34. Kullberg, B.J., Netea, M.G., Curfs, J.H.A.J., Keuter, M., Meis, J.F.G.M. and Van der Meer, J.W.M. (1998) Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans. infection in non-neutropenic mice. J. Infect. Dis. 177, 175-181.
35. Herbrecht, R., Waller, J., Koenig, H., Morier, P. and Letscher, V. (1996) Synergistic efficacy of recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated candidosis in non neutropenic mice. J. Mycol. Med. 6, 43-48.
36. Yamamoto, Y., Uchida, K., Klein, T.W., Friedman, H. and Yamaguchi, H. (1992) Immunomodulators and fungal infections: use of antifungal drugs in combination with G-CSF. In: Microbial Infections (Friedman, H., Ed.), pp. 231-241. Plenum Press, New York.
37. Graybill, J.R., Bocanegra, R. and Luther, M. (1995) Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 14, 700-703.
38. Anaissie, E.J., Vartivarian, S.E., Abi-Said, D., Uzun, O., Pinczowski, H., Kontoyiannis, D.P., Khoury, P., Papadakis, K., Gardner, A., Raad, I.I., Gilbreath, J. and Bodey, G.P. (1996) Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study. Am. J. Med. 101, 170-176.
39. Romani, L., Mencacci, A., Cenci, E., Puccetti, P. and Bistoni, F. (1996) Neutrophils and the adaptive immune response to Cmiiliila albicans. Res. Immunol. 147, 512-518.